PATENT CLAIM ANALYSIS

Application Number: 16066259
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
An embodiment of the present invention provides a novel method for diagnosing, treating, or preventing a mood disorder. The method includes the step of measuring, by using a fusion protein, a level of the anti-fusion protein antibody in a biological sample.

Claim (Index 3):
The fusion protein as set forth in  claim 1 , wherein:\n a C-terminal side of the CAML protein is bound to an N-terminal side of the SITH-1 protein.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 94.0
- Lexical Diversity: 1.42424
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15321884', '12573636', '12679816', '15462031', '13257754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7827112875353003
- 35 USC 102 Novelty (BERT): 0.5559004701188516
- Combined Prediction Score: 0.7600302057936554
- Mean Citation Score: 383.7666760000001
- Max Citation Score: 484.0693
- Similarity Product: 288.18795870450737

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test